Sano, Rhie Ann .
HRN: 24-59-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
AMPICILLIN 1GM (VIAL)
07/01/2026
07/08/2026
IV
340mg
Q6
Skin Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: